Related content

HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report

By Church D.   Bahl A.   Jones A.   Price C.  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 289-292

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

By Bartolotti Marco   Franceschi Enrico   Brandes Alba A  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1653-1664

Future Medicine

Access to resources Recommend Favorite

Occult brain metastases in HER2-positive breast cancer patients: Frequency and response to radiotherapy

By Niwinska Anna   Tacikowska Małgorzata   Pienkowski Tadeusz  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 1027-1029

Informa Healthcare

Access to resources Recommend Favorite

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

By Peddi Parvin   Hurvitz Sara  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 7-13

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients

By Iwata Hiroji   Narabayashi Masaru   Ito Yoshinori   Saji Shigehira   Fujiwara Yasuhiro   Usami Shigeyuki   Katsura Koichi   Sasaki Yasutsuna  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 621-628

Springer Publishing Company

Access to resources Recommend Favorite